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Abstract
The present study examined the relationship between an important energy-generating enzyme (cytochrome oxidase; CO), a key
energy-consuming enzyme (NaKATPase) and neurochemicals associated with excitatory glutamatergic synapses (NMDAR1
and neuronal nitric oxide synthase, nNOS) in the adult macaque retina. Polyclonal antibodies against neuronal nitric oxide
synthase and N-methyl-D-aspartate receptor subunit I were generated for immunohistochemical examination and labeled sites not
previously reported were found. We have also isolated cDNAs for cytochrome oxidase subunits III (mitochondrial-encoded) and
IV (nuclear-encoded), as well as for a fragment of neuronal nitric oxide synthase, from a human cDNA library. The distributions
of mRNAs of these genes were analyzed by in situ hybridization. We found that three or more of the markers examined coexisted
in a number of sites: (a) In the inner segments of photoreceptors, high energy demand for maintaining the dark current was placed
by NaKATPase. This was partially met by ATP-generating enzymes such as CO. Neuronal NOS was also present there for
the synthesis of NO and the cascading event leading to the generation of cGMP and the gating of channels for visual transduction.
(b) Both the outer and inner plexiform layers had detectable amounts of all four markers, although the levels varied among them.
This was most likely due to the presence of depolarizing glutamatergic synapses arising from photoreceptors and bipolar cells and
such synaptic events were energy-demanding. The involvement of NMDA receptors and nNOS in these synaptic layers is strongly
implicated in the present study. (c) All four markers were present in the majority of retinal ganglion cells, with some inherent
heterogeneity related to intensity and size. Retinal ganglion cells are known to receive excitatory synapses from glutamatergic
bipolar cells and are themselves highly active. The presence of both NMDAR1 and nNOS in these cells were verified in the present
study and the energy demands related to these synaptic activities were necessarily high. Thus, active ion transporting functions
related to synaptic or non-synaptically induced repolarization form the basis for an interrelationship between the neurochemicals:
enzymes studied. Finally, (d) all four markers and the gene expression of CO and nNOS in the macaque retina were regulated by
neuronal activity. © 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
As an extension of the central nervous system with
multiple neuronal types, the retina presents a fertile
ground for the analysis of the relationship between
energy metabolism and neural function. These two
processes are tightly coupled [1]. Neuronal activity con-
sumes energy and ATP in neurons is derived primarily
from oxidative metabolism (reviewed in [2]). While
ATP is used for a variety of cellular functions, its major
utility is to fuel active ion transporters, such as Na
KATPase, to restore and maintain resting membrane
potentials subsequent to activity-induced ionic pertur-
bations [3,1]. A key enzyme involved in ATP generation
within the mitochondria is cytochrome c oxidase (CO;
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ferrocytochrome c: oxygen oxidoreductase EC 1.9.3.1).
It is an integral protein of the inner mitochondrial
membrane, catalyzing the final step of oxidative
metabolism. Being a key oxidative enzyme, it serves as
a sensitive marker for neuronal oxidative capacity and,
indirectly, for neuronal activity. Cytochrome oxidase
activity determined biochemically is high in all regions
of the gray matter and low in the white matter [4]. At
the cellular level, its relative activity or amount revealed
histochemically or immunohistochemically varies inter-
cellularly as well as intracellularly (reviewed in [2,5]).
We have previously shown that cytochrome oxidase
activity of the rat retina assayed biochemically was
substantially lower than those of gray matter regions in
general, though significantly higher than that of the
white matter [4]. Histochemically, however, certain lay-
ers of the retina actually had very high levels of CO,
while other layers had moderate to low levels [4]. This
heterogeneous pattern was also found in other species,
including the macaque monkeys [6–8]. Immunohisto-
chemically, the relative amount of the enzyme also
varied at the laminar, sublaminar and cellular levels [9].
These results suggest that neuronal elements in the
retina have diverse energy demands.
What is the neurochemical basis for such metabolic
inhomogeneity? A reasonable link would be neuro-
chemicals associated with excitatory synapses, as the
bulk of energy expenditure in neurons is for repolariza-
tion subsequent to depolarization (reviewed in [2,5]).
Indeed, cytochrome oxidase-rich regions in the primate
visual cortex were found to contain a significantly
higher percentage of glutamatergic synapses than the
CO-poor ones [10]. Glutamate is the most prevalent
excitatory neurotransmitter in the brain [11,12] and is
the key neurotransmitter of photoreceptor cells, bipolar
cells and most ganglion cells in the vertebrate retina
[13–15]. Glutamate, in turn, activates a number of
glutamatergic receptor types in the CNS and induces a
cascade of events in postsynaptic neurons, where the
energy demand related to synaptic transmission is the
highest (reviewed in [2]). Thus, we wished to compare
the spatial distribution of cytochrome oxidase (a key
energy-generating enzyme) with those of (a) NaK
ATPase (a major energy-consuming enzyme); (b) N-
methyl-D-aspartate (NMDA) receptor, one of the
major glutamate receptors strongly implicated in activ-
ity-dependent synaptic plasticity [16–19] and (c) neu-
ronal nitric oxide synthase (nNOS), the synthesizing
enzyme of nitric oxide (NO), an inter- and intra-cellular
messenger mediating a wide range of functions and is
closely associated with and activated by NMDA recep-
tors [20,21].
Reports on NMDA receptors and nNOS in the
retina are relatively sparse. The distribution of NMDA
receptors in the primate retina is not well understood.
Neuronal NOS is thought to be expressed at low levels
in the human retina by Northern analysis [22] and, thus
far, much of its distribution is gleaned from histochem-
ical studies of NADPH-diaphorase (NADPH-d), a
marker reportedly equivalent to NOS [23,24]. Relatively
little is known of the immunohistochemical distribution
of nNOS in the mammalian retina. In an effort to
localize NMDA receptors and nNOS in the macaque
retina, we generated polyclonal antibodies monospecific
to a major subunit (subunit I) of NMDA receptors and
to the neuronal form of nitric oxide synthase (nNOS),
respectively. Their distributions were analyzed by im-
munohistochemistry in normal and tetrodotoxin
(TTX)-treated macaque retinae. TTX blocks voltage-
dependent sodium channels [25], thereby preventing
impulse generation in the retina.
To explore the gene expression of some of these
neurochemicals further, we have also isolated cDNAs
of cytochrome oxidase subunits and a fragment of
nNOS from human brain cDNA library, transcribed
them in vitro and analyzed their mRNA distributions in
the normal and TTX-treated macaque retinae by in situ
hybridization.
2. Materials and methods
2.1. Animals
All experiments were carried out in accordance with
the National Institute of Health Guide for the Care and
Use of Laboratory Animals (NIH Publications No.
80-23, revised 1978). All efforts were made to minimize
animal suffering, to reduce the number of animals used
and to utilize alternatives to in vivo techniques, when
available.
Four adult male macaque monkeys (two Macaca
mulatta and two Macaca fascicularis, 3.5–5.6 kg body
weight) were used. They were part of another study on
the visual cortex. All received monocular TTX injec-
tions (see below). At the conclusion of the experiments,
the animals were anesthetized with Ketamine hy-
drochloride (25 mg:kg, IM) and sodium pentobarbital
(60 mg:kg, IP). They were perfused intracardially with
an initial warm 0.1 M sodium phosphate-buffered sa-
line followed by cold (4°C) 4% paraformaldehyde in 0.1
M sodium phosphate buffer, pH 7.35 and 4% sucrose.
The eyes were promptly removed and placed in the
same cold fixative for 1 h. The retinae were separated
from the rest of the eye and were cryoprotected with
increasing concentrations of sucrose (10–30%) in
buffer.
2.2. Intra6itreal injections of TTX
Four adult macaque monkeys were monocularly in-
jected with TTX twice a week as described previously
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[7,26,27]. Briefly, animals were anesthetized with Ke-
tamine HCl (25 mg:kg, IM) and two drops of 0.5%
proparacaine hydrochloride were applied topically over
the corneas of the eyes to be injected. Each animal
received an intravitreal injection of tetrodotoxin (TTX,
19 mg in 10 ml of sterile water) into its left eye, close to
the limbus. We have previously found this dosage not
to block axoplasmic transport in retinal ganglion cells
of cats and macaque monkeys and the effect on cy-
tochrome oxidase activity was completely reversible
even after 4 weeks of TTX [28,26,5]. Postoperatively,
chloromycetin ophthalmic ointment (1%) was applied
to the conjunctiva as prophylaxis. The pupillary light
reflex was used as a convenient indicator of the effects
of TTX in blocking impulse transmission. The reflex
ceased about 15 min after the injection and did not
return for at least 4 days in the adult macaque. Thus,
injections were given twice a week for 1 week (one
animal), 2 weeks (two animals) and 4 weeks (one
animal).
2.3. Histochemistry and immunohistochemistry
Frozen cross-sections of the retinae from TTX-
treated and the companion non-injected eyes were cut
with a cryostat at 12 mm thickness. Retinae from the
two eyes of the same animal were mounted on the same
slides and processed concurrently. They were reacted
histochemically for cytochrome oxidase and immuno-
histochemically for NaKATPase, nitric oxide syn-
thase and NMDAR1, respectively.
2.4. Cytochrome oxidase histochemistry
Protocol was as described previously [29,6].
2.5. Immunohistochemistry
Immunohistochemistry was done as described previ-
ously [30]. Types and concentrations of primary anti-
bodies used were as follows:
1. anti-NaKATPase: Monoclonal antibodies
against a3 subunit of canine heart NaKAT-
Pase was obtained from Affinity BioReagents
(Golden, CO) and used at a concentration of
1:1500.
2. anti-nNOS: Antisera were generated in our labora-
tory against synthetic peptide corresponding to
amino acids 100–118 at the N-terminus of neu-
ronal NOS. This segment is part of the first 220
amino acids that are unique to the neuronal form
of NOS [21]. The protocol for antibody generation
was as described previously [31]. Briefly, peptides
were synthesized on a MilliGen 9050 peptide syn-
thesizer using the solid phase method (Protein:Nu-
cleic Acid Shared Facility, Medical College of
Wisconsin). Synthetic peptides were coupled to the
carrier protein keyhole limpet hemocyanin (KLH)
via a glutaraldehyde linkage and were used to im-
munize young female New Zealand white patho-
gen-free rabbits. Antisera were analyzed with
ELISA and Western blots for titer and specificity.
The concentration for immunohistochemistry was
1:1000.
3. anti-NMDAR1: Polyclonal antibodies were gener-
ated in our laboratory against a synthetic peptide
corresponding to amino acids 860 to 873 close to
the C-terminus of human NMDAR1 subunit [32].
Antibody generation and analysis were the same as
for nNOS (see above). The concentration of antis-
era used was in the range of 1:1000–1:2000.
2.6. Combined immunohistochemistry and immuno-gold
sil6er staining (IGSS) method on the same section
Frozen sections of macaque retinae were doubly im-
munolabeled for nNOS and NMDAR1, using ap-
proaches described previously [33,34]. Sections were
first processed with the immuno-gold silver staining
(IGSS) method for NOS, then they were labeled for
NMDAR1 with the indirect immunoperoxidase
method. Briefly, sections were first blocked in 10%
normal goat serum (NGS) in phosphate buffered saline,
pH 7.6 (PBS) overnight at 4°C. Anti-bNOS antibodies
were diluted in 5% NGS to 1:10000 and applied to
sections for 4 h at RT and overnight at 4°C. After
incubation with immunogold (goat anti-rabbit IgG, 10
nm gold conjugate, 1:100 in PBS) for 4 h at RT, signals
were detected with IntenSE M (Amersham, Arlington
Heights, IL) for 18–21 min in the dark. Between steps,
sections were rinsed in PBS three times. Prior to and
after IntenSE M, the sections were rinsed with filtered
tap water. Sections were then incubated in our anti-
NMDAR1 antibodies (1:1000) for 4 h at RT and
overnight at 4°C, followed by secondary antibodies
(goat-anti-mouse IgG-HRP) for 4 h at RT. Signals were
detected with diaminobenzidine.
2.7. Controls for immunohistochemistry
Sections were processed in the same way as for the
specific antibodies, except that (a) primary antisera
were omitted or substituted with normal goat sera; or
(b) preimmune sera (for anti-nNOS or anti-NMDAR1)
were used.
2.8. Isolation of CO subunits III and IV cDNAs
Oligonucleotides were synthesized as primers for iso-
lating CO subunits III (mitochondrial) and IV (nuclear)
from a human brain cDNA library. Synthesis was
performed by the Protein:Nucleic Acid Shared Facility
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of the Medical College of Wisconsin. Each set of
primers had its nucleotide sequences corresponding
close to or at the 5% and 3% ends of known human CO
III [35] and human liver CO IV genes [36], respectively.
Primers 1 and 2 for CO III were: 5%-ACCCACCAAT-
CACATGCCT-3% and 5%-ACAAAATGCCAGTAT-
CAGGC-3%, corresponding to nucleotides c9210–9228
at the 5% end and nucleotides c9921–9940 at the 3%
end, respectively, of the human mitochondrial genome
(Fig. 3; primers are indicated by italics). Those for CO
IV were: 5%-ATGTTGGCTACCAGGGTATT-3% and
5%-CTTCCACTCGTTCTTTTCGT-3%, corresponding
to nucleotides c1-20 at the 5% end and nucleotides
c485-504 at the 3% end, respectively (Fig. 4). All
primers were designed to have a Tm of 58°C. Synthe-
sized primers were desalted and used in a polymerase
chain reaction (PCR) to isolate and amplify CO III and
IV genes from a human brain cDNA library (Strata-
gene, La Jolla, CA). PCRs were done with a hot start
and 30 cycles of denaturation (94°C), anneal (53°C) and
elongation (72°C). Amplified PCR products were run
on a 1.5% low-melting agarose gel, stained with ethid-
ium bromide for size verification, excised from the gels
and purified with the Qiaex kit (Qiagen, Chatsworth,
CA).
2.9. Isolation of a fragment of neuronal NOS
Afragment of neuronal NOS (nNOS) corresponding
to amino acids 705–903 and encompassing the
calmodulin binding site [21] was isolated from the
human cDNA library by PCR and purified as de-
scribed above. Primers used were based on amino
acid sequence of rat brain NOS [37]: 5%-ATACCAGC-
CTGATCCATGG-3% and 5%-CAGGAGGGTGTC-
CACCG-3%, respectively (Fig. 11; primers are shown
in italics).
2.10. Subcloning and sequencing
The isolated CO III, CO IV and nNOS cDNAs
were subcloned into the EcoRI site of plasmid
pCR™II (TA cloning kit, Invitrogen, San Diego, CA)
which contained phage SP6 and T7 promoters. The
plasmids have the lacZ gene for blue:white color se-
lection and the Ampicillin resistance gene. The plas-
mids with inserts were amplified in white colonies of
transformed OneShot competent cells (Invitrogen) and
purified on a Qiagen plasmid column, according to
the manufacturer’s instructions (Qiagen). Purified
plasmids were digested with EcoRI for size confirma-
tion (Fig. 2A,B, and 12A). Insert DNAs were then
sequenced by the dideoxy sequencing method of
Sanger et al. [38] using either Vistra DNA Sequencer
725 or ABI Prism 377.
2.11. Riboprobe synthesis
Antisense and sense riboprobes for CO III, CO IV
and nNOS were generated by in vitro transcription
using sets of restriction enzymes and RNA poly-
merases (BamHI and T7 for the sense strand and
EcoRV and Sp6 for the antisense strand for all 3
cDNAs). Riboprobes were labeled with a-35S-thioUTP
(uridine 5%-[a-35S-thio]triphosphate; 1250 Ci:mmol
from Amersham) or with digoxigenin-11-UTP
(Boehringer-Mannheim, Indianapolis, IN) according
to the manufacturer’s instructions and as described
previously [39,40].
2.12. Light microscopic in situ hybridization
Frozen 12 mm sections of macaque retinae were cut
on a cryostat, thaw mounted on slides coated with
gelatin (300 Bloom, Sigma):chromium potassium sul-
fate and frozen at 80°C until the day of use. Solu-
tions for in situ hybridization were treated with 0.1%
diethylpyrocarbonate (DEPC) to destroy RNAse ac-
tivity and autoclaved. Protocols for in situ hybridiza-
tion of cryostat sections, including immunohisto-
chemistry of digoxigenin-labeled probes and autora-
diography for detecting 35S-labeled probes, were as
described previously [39,40]. Antisense riboprobes
were used to hybridize with CO III, CO IV and
nNOS mRNAs, respectively and sense riboprobes
were used as controls for nonspecific binding.
2.13. Optical densitometry
The intensities of histochemical or immunohisto-
chemical reaction product of CO, NaKATPase,
NMDAR1 and nNOS in various retinal layers of
paired control and 4-week TTX-treated eyes were an-
alyzed by optical densitometry. A Zeiss Zonax MPM
03 photometer system was used with a final measur-
ing spot size of 2 mm diameter. The background was
subtracted by setting zero over a blank area (without
tissue) in each slide. All lighting conditions, magnifi-
cations and reference points were kept constant. At
least 25 readings (each being the average of 15 read-
ings obtained by the Zonax system) of each layer,
sublayer, or cell type for each marker were taken for
each eye and their mean optical densities9S.E.M.
were determined.
The intensities of digoxigenin-labeled antisense for
CO III, CO IV and nNOS in cells of the ganglion cell
layer of control and 4-week TTX-treated retinae were
also measured. Two micron spot-size readings were
taken from the cytoplasm of at least 50 ganglion cells
for each eye and for each type of marker (CO III,
CO IV and nNOS antisense riboprobes).
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3. Results
3.1. Cytochrome oxidase
3.1.1. Histochemical localization in the macaque retina
Cytochrome oxidase exhibited a distinct pattern of
distribution in the adult macaque retina (Fig. 1A,C), in
agreement with our previous reports [6,7,9]. The inner
segments (IS) of photoreceptor cells showed the most
intense labeling. A row of regularly spaced cone pedi-
cles was also highly reactive, as was the rest of the
outer plexiform layer (OPL). The inner plexiform layer
(IPL) was moderate to darkly reactive and at times
had a relatively clear zone between sublaminae a and
b. Sublamina b was often more reactive than sublam-
ina a, especially in the central retina. With regard to
cell bodies, horizontal cells at the outer edge of the
inner nuclear layer (INL) were highly reactive. Bipolar
cells in the outer third of INL were moderate-to-darkly
reactive, while most of the cells in the vitreal portion
of INL (presumed amacrine cells) were only lightly
reactive. Ganglion cells (GC) had a heterogeneous pat-
tern of labeling, with the larger ones, in general, being
much more reactive than the medium and small cells
(Fig. 1C). Most of the ganglion cells in central retina
tended to be moderate to darkly reactive. Photorecep-
tor cell bodies in the outer nuclear layer (ONL)
showed very low levels of CO and their outer segments
(OS) are unreactive. The nerve fiber layer (NFL)
within the retina had moderate to high levels of en-
zyme activity. As reported previously, once the gan-
glion cell axons leave the retina and acquire myelin
sheaths, the level of CO drops precipitously [6].
3.1.2. Effect of intra6itreal injections of tetrodotoxin
Intravitreal retinal impulse blockade caused a reduc-
tion in cytochrome oxidase activity within IPL (both a
and b sublaminae), retinal ganglion cell layer and
nerve fiber layer (PB0.0001 for all) (Fig. 1B,D). These
represent cell bodies and processes of ganglion cells
whose voltage-dependent sodium channels were inacti-
vated by TTX. The rest of the retina appeared rela-
tively normal and, despite up to 4 weeks of treatment,
the retinae retained their structural integrity. The gen-
eral pattern of staining also remained essentially the
same as normal. Again, the present findings were in
agreement with our previous reports [7,9]. Qualitative
changes were confirmed by optical densitometric anal-
ysis of reductions in CO levels in various retinal struc-
tures (Fig. 1E).
3.1.3. Specificity of cytochrome oxidase subunit cDNAs
(CO III and CO IV)
Gel electrophoresis of PCR product isolated from
human brain cDNA library revealed a single band
each for CO III (731 base pairs) and CO IV (504 bp),
comparable in sizes to those published ([35,36], respec-
tively). Subsequent to cloning and purification, cDNAs
released from their respective plasmids by restriction
digest were also of the appropriate sizes (Fig. 2A, B).
DNA sequence analysis indicated that CO III cDNA
generated from the human brain (Fig. 3) shared 99.7%
identity with the published sequence for human ge-
nomic CO III [35]. There was a G353C substitution,
which converts arginine to proline and a T492C silent
substitution for leucine (Fig. 3, with the triplet codon
underlined). Since the mitochondrial-encoded CO III is
highly conserved, we are not certain if these substitu-
tions were brain-specific or if they were technique-in-
duced. The sequence for CO IV (Fig. 4) was 100%
homologous with that of the human liver [36].
3.1.4. Expression of CO III and CO IV in the
macaque retina
mRNAs for both mitochondrial-encoded CO III and
nuclear-specified CO IV were localized to cell bodies of
the macaque retina with either radioactive or nonra-
dioactive antisense probes. The patterns were similar
between the two CO subunits. In non-radioactive,
digoxigenin-labeled preparations (Fig. 5A,E), the gan-
glion cell layer showed the most intense signal for both
subunits. Cell bodies of the inner nuclear layer were
generally moderately labeled, but a few of them with
darker signals were present along the vitreal portion of
INL (presumed amacrine and displaced ganglion cells;
arrows in Fig. 5A,E) as well as scattered within the
INL (presumed bipolar and horizontal cells). Photore-
ceptor cell bodies in ONL were primarily lightly la-
beled, with occasional ones having a stronger signal.
The inner segments of photoreceptors had no de-
tectable staining above background. In radioactively
labeled prepara
tions (Fig. 5C,G), retinal cell bodies (especially those in
the ganglion cell layer) were highlighted by silver grains.
In addition, label also appeared to accumulate in the
inner segments of photoreceptors. However, it should be
noted that the inner segments had inherent refractive
properties that showed up in dark field (Fig. 5D,H). This
was clearly distinguishable from the overlying silver
grains in antisense preparations under bright field (not
shown). The sense strands for both non-radioactive (Fig.
5B,F) and radioactive probes (Fig. 5D,H) of CO III and
CO IV showed no labeling above background.
3.1.5. Effect of monocular TTX on CO subunit mRNA
expression in the macaque retina
Monocular intravitreal injections of TTX for 1–4
weeks induced a significant down-regulation of CO III
and IV subunit genes, primarily in the ganglion cell layer.
This indicates that the reduction of CO activity in this
layer resulted mainly from a neuronal readjustment of
their gene expression. Analysis by optical densitometry
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Fig. 1. — Legend opposite.
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Fig. 2. Agarose gel electrophoresis of cytochrome oxidase subunit III (A, lane 2) and subunit IV (B, lane 2) cDNAs isolated and amplified by PCR
from a human brain cDNA library, cloned in pCR™II vector and released by restriction digest. Lane 1 in each case contains 1 kb ladder, with
base pair sizes indicated on the left. Arrows show a single band each that is of the expected size for our CO III cDNA (731 base pairs) and CO
IV (504 bp), respectively, with the vectors for each at about 3.9 kb.
of digoxigenin-labeled CO III and CO IV antisense in
perikarya of the ganglion cell layer after 2 weeks (not
shown) and 4 weeks of TTX (Fig. 6) revealed that the
reduction was significant for both CO III and CO IV
mRNAs (PB0.001 for both subunits and at both
survival times). However, the degree of labeling in
ganglion cells remained significantly higher than those of
other cell types, indicating that these neurons are able to
sustain a relatively stable level of message expression, at
least within the time period examined. The other cell
layers were not analyzed, as they exhibited low levels of
labeling in both normal and TTX-treated retinae.
3.2. NaKATPase
Immunohistochemical localization of this plasma
membrane protein pump was at sites of high ion trans-
porting function: the inner segments of photoreceptors,
the outer plexiform layer, the inner plexiform layer and
the nerve fiber layer before the axons became myelinated
(Fig. 7A). Of these, the OPL showed the most intense
labeling, with punctate extensions in the outer third of
the OPL (arrows in Fig. 7A,B) that could represent
horizontal and:or bipolar endings postsynaptic to pho-
toreceptor terminals. Cone inner segments had more
intense immunolabeling than those of rods, consistent
with a denser CO concentration in the former than in the
latter. The IPL was only moderately immunoreactive,
while the nerve fiber layer was intensely labeled. Cell
bodies were also outlined by NaKATPase (Fig. 7B),
with those in the ganglion cell layer exhibiting varying
intensities of labeling. Cells toward the outer half of INL
were more immunoreactive than those toward the vitreal
half of INL and cells in ONL showed relatively little
labeling. These were all features that closely paralleled
those of CO activity.
(Fig. 1 opposite)
Fig. 1. Cytochrome oxidase histochemistry of the macaque retina. The pattern is similar to those described previously (see text). The layers are
indicated on the left. (A) Note that CO activity is high in inner segments (IS) of photoreceptors, cone pedicles (small arrows), the outer plexiform
layer (OPL), sublamina a and b of the inner plexiform layer (IPLa, b), ganglion cell layer (GCL) and nerve fiber layer (NFL) within the retina.
The outer portion of the inner nuclear layer (INL), including horizontal cell bodies, is more reactive than the inner part, while the outer segments
(OS) of photoreceptor cells and the outer nuclear layer ONL) have little or no detectable CO activity. PE, pigment epithelium. (B) After 4 weeks
of intravitreal TTX, the level of enzyme is reduced in IPL, GCL and NFL. (C and D) Higher magnifications of normal and TTX-treated retinae
showing cone pedicles (small arrowheads), OPL, INL, IPL and GCL. Note that the intensity of labeling varies among cells of GCL, with the larger
ones (solid arrowhead) being darkly reactive and some of the smaller ones were lightly reactive (open arrowhead). This difference is retained even
when the overall activity of CO in GCL is reduced by TTX (D). (E) Optical densitometric analysis of CO reaction product in various retinal layer.
The values from control retinae are compared with those from eyes treated for 4 weeks with TTX. Asterisks for this and other graphs indicate
P values derived from Student’s t-test. CP, cone pedicles.
M.T.T. Wong-Riley et al. : Vision Research 38 (1998) 1455–14771462
Fig. 3. DNA and deduced amino acid sequences of human brain cytochrome oxidase subunit III cDNA are shown in comparison with published
sequence from the human mitochondrial genome [35]. Nucleotides are numbered on the right, amino acids on the top. Primers for isolating the
human brain cDNA are shown in italics. Nucleotide triplets in which a difference was observed are underlined and the one that led to an amino
acid substitution is indicated with an asterisk. (See text for details).
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Fig. 4. DNA and deduced amino acid sequences of human brain cytochrome oxidase subunit IV cDNA are shown in comparison with published
sequence from the human liver [36]. There is 100% homology between the two. Nucleotides are numbered on the right, amino acids on the top.
Primers for isolating the human brain cDNA are shown in italics.
3.2.1. Effect of monocular impulse blockade on
NaKATPase
One to 4 weeks of monocular TTX injections
caused a significant reduction in the intensity of Na
KATPase immunoreactivity, primarily in the nerve
fiber layer of TTX-treated retinae as compared to the
untreated controls (PB0.001) (Fig. 7C). There was
also a reduction in the OPL that was significant at a
PB0.01 level. Changes in the ganglion cell layer were
more difficult to ascertain, as the labeling was
confined primarily to the plasma membrane (i.e. even
with the smallest measuring aperture available of 2
mm diameter, values would include unlabeled cyto-
plasm and be severely underestimated). Overall, reduc-
tions were relatively mild, though statistically
significant.
3.3. NMDAR1
3.3.1. Characterization of our anti-NMDA receptor
subunit I (NMDAR1) antibodies
In Western blots, our anti-NMDAR1 antibodies re-
acted with a single band of proteins with molecular
weight of :105 kDa (Fig. 8C, lane 1), corresponding to
the known size of human NMDAR1 [32]. Preimmune
sera exhibited no cross-reactivity (Fig. 8C, lane 2).
In immunohistochemically reacted sections, NM-
DAR1 exhibited a distinct pattern of labeling (Fig.
8A,B). Neurons in the ganglion cell layer were im-
munoreactive to varying degrees and larger cells tended
to be more darkly immunoreactive (Fig. 8B, solid arrow-
head) than smaller ones (Fig. 8B, open arrowhead).
This was the case in both central and peripheral retina.
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Fig. 5. In situ hybridization using digoxigenin-labeled (A, B, E, F) or 35S-labeled (C, D, G, H) riboprobes against cytochrome oxidase subunit
III (A-D) and subunit IV (E–H) in the macaque retina. Note that the antisense (AS) label is most intense in the ganglion cell layer (small white
arrows in C and G). It is moderate in the inner nuclear layer and light in the outer nuclear layer. Scattered cells, especially those along the inner
border of INL, are also labeled (arrows in A and E). Sense (S) controls labeled either with digoxigenin (B, F) or 35S (D, H) show no signal above
background. A low amount of signal is apparent in the inner segments of photoreceptors with 35S-labeled antisense probes (C, G). However, there
is an inherent refractive property of the inner segments seen in darkfield (C, D, G, H), which can be clearly differentiated from silver grains at
higher magnifications under bright field (not shown).
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Fig. 6. Quantitative analysis of the effect of 4 weeks of monocular TTX on cytochrome oxidase subunits III and IV gene expression in the retinal
ganglion cells of adult macaque monkeys. Optical densitometry was used to measure the intensity of digoxigenin-immuno-reaction product
representing mRNAs for CO III and CO IV, respectively. There were statistically significant reductions in both subunit mRNAs after TTX
inactivation (PB0.001 for both).
Cells in the vitreal portion of INL, interpreted to be
amacrine, were moderate- to darkly-immunoreactive
for NMDAR1 (Fig. 8B, thin arrows). The OPL was
moderate- to darkly-immunoreactive, while IPL and
NFL were only light- to moderately-immunoreactive. A
thin band of light to moderate immunoreactivity was
present at the innermost portion of photoreceptor inner
segments, including the region corresponding to the
outer limiting membrane. The photoreceptor cell bodies
themselves were not visibly immunoreactive.
3.3.2. Effect of monocular impulse blockade on
NMDAR1
One to 4 weeks of monocular TTX treatment led to
a significant reduction in NMDAR1 immunoreactivity
in IPLa, IPLb, in presumed amacrine cells along the
inner borders of INL and in the ganglion cell layer of
TTX-treated retinae as compared to the untreated con-
trols (PB0.001 for all) (Fig. 8D shows data from 4
weeks of TTX).
3.4. Neuronal nitric oxide synthase (nNOS)
3.4.1. Characterization of our anti-neuronal NOS
antibodies
Since the first 220 amino acids of neuronal NOS are
unique to this isoform and not present in either en-
dothelial NOS or inducible NOS [21], we generated
polyclonal antibodies against a synthetic peptide whose
sequence corresponded to amino acids 100–118 at the
amino terminus of nNOS. Western blots showed a
single band of cross-reactivity, :155–160 kDa (Fig.
9C, lane 1), corresponding to the known size of neu-
ronal NOS [21]. Preimmune sera exhibited no cross-re-
activity (Fig. 9C, lane 2).
The immunohistochemical pattern revealed by our
anti-nNOS antibodies (Fig. 9A,B) was similar, though
much more distinct, than those from commercial
sources (e.g. Transduction Lab; not shown). The OPL
was the most darkly immunoreactive, while the IPL
exhibited two bands of moderate to dark labeling, with
a distinctly clear zone in between (stratum 3 of [41])
(Fig. 9B, outlined by parentheses). Cells in GCL had
varying intensities of immunoreactivity, ranging from
light to moderately dark (Fig. 9B, open and solid
arrowheads, respectively). Scattered cells close to the
vitreal side of INL, interpreted to be amacrine cells,
also showed moderate to high levels of immunoreactiv-
ity (Fig. 9B, thin arrow). The inner segments of pho-
toreceptors, especially the myoid portion and the
adjacent outer limiting membrane region, were moder-
ately immunoreactive, while NFL, ONL and outer
segments were all quite light.
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Fig. 7. Cross section of the macaque retina immunoreacted for NaKATPase (A; enlarged in B). The labeling is most intense in OPL (with
processes extending toward ONL; arrows in A and arrowheads in B), inner segments of photoreceptors and NFL, while the IPL is moderately
labeled. Retinal cells are also outlined by the enzyme, with ganglion cells showing a heterogeneous pattern of labeling and cells in the outer half
of INL more darkly labeled than those in the inner half. Intravitreal TTX for 4 weeks caused a significant reduction in the intensity of
NaKATPase immunoreactivity, primarily in NFL and also in the OPL (C).
3.4.2. Effect of monocular impulse blockade on nNOS
One to 4 weeks of monocular TTX treatment led to
a significant reduction of immunoreactivity for nNOS
in the ganglion cell layer of TTX-treated retinae as
compared to the untreated controls (PB0.001). The
OPL also showed a decrease in immunostaining (PB
0.01). Surprisingly, IPLb exhibited an increase in im-
munolabeling (especially in stratum 4) that was also
M.T.T. Wong-Riley et al. : Vision Research 38 (1998) 1455–1477 1467
Fig. 8. NMDAR1 in the macaque retina. (A) Immunohistochemical labeling of NMDAR1 in the macaque retina (enlarged in B). Note that cells
in the ganglion cell layer have heterogeneous intensities of staining (solid and open arrowheads in B represent darkly- and lightly-immunoreactive
cells, respectively). A subset of presumed amacrine cells along the inner borders of INL is labeled (arrows in B). The OPL is moderate- to
darkly-immunoreactive, both a and b sublaminae of IPL are moderately labeled and the base of photoreceptor inner segments, possibly including
the outer limiting membrane, is also moderately immunoreactive. (C) Western blot analysis (7.5% SDS-PAGE) of homogenized macaque brain
tissue incubated with our anti-NMDAR1 antibodies, showing a single immunoreactive band of :105 kDa representing NMDAR1 (lane 1). The
positions for molecular weight markers are shown on the left and lane 2 is the preimmune control. (D) Intravitreal TTX for 4 weeks caused a
significant decrease in the intensity of NMDAR1 immunoreactivity in IPL, amacrine cells and ganglion cells.
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Fig. 9. Neuronal NOS in the macaque retina. (A) Immunohistochemical labeling of nNOS in the macaque retina (enlarged in B). Note the
heterogeneous labeling of cells in the ganglion cell layer (solid and open arrowheads in B represent darkly- and lightly-immunoreactive cells,
respectively). Immunoreactivity of a subset of presumed amacrine cells along the inner borders of INL (arrow in B) is also higher than immediately
adjacent cells. The OPL is darkly-immunoreactive and both a and b sublaminae of IPL are moderate-to-darkly immunoreactive, with a thin band
of lighter staining in between (indicated by parentheses in B). Photoreceptor inner segments are also moderately immunoreactive. (C) Western blot
analysis (7.5% SDS-PAGE) of homogenized macaque brain tissue incubated with our anti-nNOS IgG, showing a single immunoreactive band of
155–160 kDa representing nNOS (lane 1). The positions for molecular weight markers are shown on the left and lane 2 is the preimmune
control. (D) Intravitreal TTX for 4 weeks caused a significant reduction in the intensity of nNOS immunoreactivity in ganglion cells and in the
OPL. However, IPLb exhibited an increase in immunoreactivity with TTX.
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Fig. 10. (A) Double labeling of nNOS and NMDAR1 in the same section (enlarged in B). nNOS is indicated by silver grains (by means of
immunogold silver staining), while NMDAR1 is revealed by the immunoperoxidase method. The pattern for each marker is identical to that in
singly-reacted sections (compare with Fig. 8A,B and 9A,B). Note that OPL, IPLa,b, some presumed amacrine cells (thin arrows in B) and some
ganglion cells (double sold arrowheads in B) are double-labeled. However, the middle portion of IPL (marked by parentheses in B) is clearly not
immunoreactive for nNOS. Furthermore, some ganglion cells are immunoreactive only for NMDAR1 (solid arrowhead in B), while others are
labeled only for nNOS (open arrowheads in B).
statistically significant (PB0.001). The reason for this
increase is unclear at present. Amacrine cells them-
selves, however, did not reveal any significant change in
their labeling intensity (Fig. 9D).
3.4.3. Double labeling of NMDAR1 and nNOS
In sections doubly immunoreacted for nNOS and
NMDAR1, the two markers could be clearly differenti-
ated within the same section (Fig. 10A,B). Brown reac-
tion product represented NMDAR1 immunoreactivity,
while silver grains belonged to nNOS labeling. The
pattern revealed by each marker corresponded precisely
to those shown with single labeling (refer to Fig. 8A,B
and 9A,B). In addition, some neurons close to the vitreal
side of INL (interpreted to be amacrine) were doubly
labeled by both markers (Fig. 10B, thin arrows), as were
a number of neurons in the GCL (Fig. 10B, double
arrowheads). However, there were also ganglion cells
that were singly labeled for either NMDAR1 (Fig. 10B,
solid arrowhead) or nNOS (Fig. 10B, open arrowheads).
3.4.4. Specificity of neuronal NOS cDNAs
Gel electrophoresis of PCR product isolated from
human brain cDNA library revealed a single band of the
expected size (:595 bp) (not shown). Subsequent to
cloning and purification, the cDNA released from the
plasmids by restriction digest was also of the appropriate
size (Fig. 12A).
DNA sequence analysis indicated that nNOS cDNA
fragment generated from the human brain shared 99.3%
identity with the sequence published for the human
retinal nitric oxide synthase [22] (Fig. 11). The dis-
crepancy was caused mainly by the two primers, which
were designed from the amino acid sequence of rat brain
NOS ([37]; the only brain sequence known at the time
when we started the project) and they each differed from
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Fig. 11. DNA and deduced amino acid sequences of our human nNOS cDNA fragment are shown in comparison with published sequence from
the human retina [22]. Nucleotides are numbered on the right, amino acids on the top. Primers for isolating the human brain cDNA are based
on the rat brain amino acid sequence and are shown in italics. Thus, each primer differed from the human retinal nNOS by one nucleotide (C16A
and T580G, respectively). Nucleotide triplets in which one or more sequences differ between the published sequence and ours are underlined.
There was also a C73T silent substitution for isoleucine. The remaining sequence of nNOS fragment from the human brain was 100% identical
to that of the human retina.
the reported human retinal nNOS by one nucleotide
(C16A and T580G, respectively; Fig. 11). However,
there was also a C73T silent substitution for isoleucine
within the coding region for the calmodulin binding
site. It is possible that this difference was artifactually
induced in the PCR reaction, rather than a true substi-
tution. The remaining sequence of nNOS fragment
from the human brain was 100% identical to that of the
human retina.
3.4.5. Expression of nNOS in the macaque retina
In situ hybridization of digoxigenin-labeled (Fig.
12C) or 35S-labeled (Fig. 12E) antisense nNOS ribo-
probes revealed intense labeling of cells in the ganglion
cell layer (Fig. 12C). Cells in the INL were moderately
labeled, with a few more darkly labeled ones along the
vitreal border. Those in the ONL were only light- to
moderately-labeled. Sense controls showed no labeling
above background (Fig. 12D,F).
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Fig. 12. (A) Agarose gel electrophoresis of a fragment of nitric oxide synthase (lane 2) isolated and amplified by PCR from a human brain cDNA
library, cloned in pCRII vector and released by restriction digest. Lane 1 contains the 1 kb ladder, with base pair sizes indicated on the left.
Arrows show a single band that is of the expected size for the cloned fragment of nNOS (595 base pairs), with the vectors at about 3.9 kb. In
situ hybridization using digoxigenin-labeled (C) or 35S-labeled (E) antisense (AS) riboprobes against nNOS in the macaque retina showed that the
label is most intense in the ganglion cell layer (small arrows in E), moderate in the inner nuclear layer and light in the outer nuclear layer. A subset
of presumed amacrine cells along the vitreal border of INL is also labeled. Sense (S) control labeled with either digoxigenin (D) or 35S (F) showed
no labeling above background. The inherent refractiveness of the inner segments (seen in sense control, F) can be distinguished from true signal
at a higher magnification under bright field (not shown). (B) After intravitreal TTX for 4 weeks, nNOS gene expression is down-regulated in the
ganglion cell layer.
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3.4.6. Effect of monocular TTX on nNOS mRNA
expression in the macaque retina
Monocular impulse blockade for 1–4 weeks induced
a significant decrease in the intensity of mRNA labeling
of nNOS in cells of the ganglion cell layer as seen with
in situ hybridization. The difference is significant even
after 4 weeks of TTX treatment (PB0.01; Fig. 12B).
4. Discussion
The present study demonstrates that there is a het-
erogeneous but distinct pattern of distribution for each
of the four neurochemical markers examined in the
macaque retina: cytochrome oxidase, NaKATPase,
NMDA receptor subunit I and nitric oxide synthase.
Their similar (though not identical) patterns support a
functional link between glutamate-related postsynaptic
neurochemicals (NMDA receptor and NOS) and en-
zymes of energy metabolism (cytochrome oxidase and
NaKATPase) in major portions of the retina.
4.1. Cytochrome oxidase
Results from our present study are consistent with our
previous reports on retinae of primate and other species
[6–9,34]: (1) Labeling is heterogeneous among laminae,
sublaminae, cells and compartments of cells. (2) Labeling
is most intense in the inner segments of photoreceptor
cells. This is the region responsible for maintaining the
‘dark current’ [42,43] and is the site of active ion
transport. It also has a dense collection of mitochondria
that are darkly reactive for CO [6]. (3) Cone pedicles,
horizontal cells and large ganglion cells are darkly
reactive for CO. They have previously been found to be
distributed in mosaic arrays [6]. (4) Both the outer and
inner plexiform layers have moderate to high levels of
CO, consistent with a high energy demand for synaptic
activities. Finally, (5) the level of CO in cell bodies often
do not correlate with those of their processes. Photore-
ceptor cell bodies, for example, have very low levels while
their inner segments are darkly reactive for CO. This
illustrates the ability of neurons to control their energy
metabolism at an exquisitely local level [2].
4.2. Cytochrome oxidase subunits III and IV cDNAs
and gene expression
Mammalian cytochrome oxidase holoenzyme is made
up of 13 subunits in a 1:1 stoichiometry [44] and is
bigenomic. The largest three subunits (I, II and III) are
encoded in the mitochondrial DNA and comprise the
catalytic core of the enzyme [45]. Subunit III is an
integral membrane protein with seven putative
transmembrane helices [46] and is essential for the
biosynthesis and assembly of the functional holoenzyme
[47]. It is thought to provide structural stability for the
active enzyme, assist in the final folding of CO subunit
I, or indirectly influence proton translocation by affect-
ing the conformation of the enzyme [48]. Mutation of
this subunit is implicated in certain forms of Leber’s
hereditary optic neuropathy, where varying degrees of
visual loss is found in conjunction with impaired CO
activity [49,50].
The other ten, smaller subunits are encoded in the
nuclear DNA and are synthesized on cytoplasmic ribo-
somes [51]. Their functions are unknown, but allosteric
modification and regulation of enzymatic activity have
been suggested [44,51–54]. We have previously found
that subunit IV forms a precursor pool in dendrites,
where local energy demand presumably dictates its
processing into the mature form [31].
Our subunits CO III and CO IV cDNAs derived
from the human brain have been confirmed to be of the
correct sizes and they share 99.7 and 100% sequence
identity, respectively, with reported CO III from human
mitochondrial genome [35] and human liver CO IV
[36]. Antisense riboprobes generated from these cDNAs
label specific cell types in the macaque retina, indicating
that human and macaque CO subunits probably share
substantial sequence homology in the coding regions
Retinal ganglion cells exhibit the most intense label-
ing for both CO III and CO IV subunits, shown with
either radioactive or non-radioactive riboprobes. Gan-
glion cells receive exclusively excitatory synapses from
bipolar cells [55], whose neurotransmitter is glutamate
[15]. Thus, ganglion cells of both ON-center and OFF-
center types are driven by their respective bipolar cells
in IPLb and IPLa and energy is needed to restore their
resting membrane potential subsequent to excitatory
depolarizing activities. While all ganglion cells have
relatively high levels of CO activity and CO gene
expression, the most intensely labeled ones tended to be
the larger cells. They correspond in size to M cells [56]
and probably project to the magnocellular layers of the
lateral geniculate nucleus, where CO activity has also
been shown to be the highest [57].
The other retinal neurons have relatively low levels of
gene expression for both CO subunits examined, with
the exception of an occasional cell toward the vitreal
border of IPL. These are presumed amacrine cells that
may receive excitatory input from glutamatergic bipolar
cells as well.
4.3. Regulation of CO subunit mRNAs
Cytochrome oxidase activity has previously been
shown to be tightly regulated by neuronal activity
(reviewed in [2]). Changes in CO activity in the
macaque visual system primarily reflect changes in CO
protein levels [9], which, in turn, are regulated by
mitochondrial DNA and CO subunit mRNAs [39,58].
The present study extends these findings to the
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macaque retina and demonstrates that monocular retinal
impulse blockade induces a significant down-regulation
of both subunit messages in the deprived ganglion cells
(PB0.001 for both subunits). This indicates that neu-
ronal activity plays an important role in regulating the
expression of both mitochondrial—and nuclear—CO
genes in neurons of the primate retina.
4.4. NaKATPase in the retina
Not surprisingly, the retinal distribution of a key
energy-consuming enzyme, NaKATPase, closely
correlates with that of CO, a major energy-generating
enzyme. The inner segments of photoreceptors, especially
those of cones, are most intensely labeled by both
enzymes. Other sites rich in both enzymes are the OPL,
IPL and NFL, which are involved in synaptically driven
active ion pumping ([34] the present study). In the OPL,
immuno-reaction product for NaKATPase may
reside in cone pedicles, bipolar cell dendrites and hori-
zontal cell processes. Some of these processes extend
toward ONL in bulbous terminals with short stalks and
may represent H1 horizontal cell processes which contact
rod spherules at ribbon synapses [59]. The exact identity,
however, awaits further electron microscopic verifica-
tion.
4.5. NMDAR1
Even though glutamate is the major excitatory neuro-
transmitter throughout the retina [13,60,14,15], the dis-
tribution of one of its key receptor types, NMDA, was
thought to commence only at the level of ganglion cells
[61,62]. Most of the studies were done on birds, fish and
subprimate mammals and relatively little is known about
their distribution in the macaque retina. Hartveit and
colleagues found that one of the subunits of NMDA
receptors, NR2A, was localized to the IPL in a number
of species, including monkeys. However, no retinal cell
bodies were reported to be immunoreactive, although
NR2A message was clearly expressed in almost all
ganglion cells and a subset of amacrine cells [63]. We
chose subunit I of NMDA receptors (NMDAR1) as our
immunogen, because this subunit has the most abundant
distribution in the brain and is an essential component
for normal receptor function [18]. NMDAR1 also coex-
ists in cells that contain the non-NMDA receptor sub-
units, GluR2:3 and GluR5:6:7 [64]. Thus, the
distribution of NMDAR1 subunits reflects the majority,
if not all, NMDA receptor complexes and perhaps even
indicate the locations of some non-NMDA ionotropic
glutamate receptors [18,64].
Our anti-NMDAR1 antibodies cross-react with a
protein band that is of the correct size for known NMDA
receptors [32]. Immunohistochemically, the moderately
stained OPL and the light-to-moderately labeled IPL
probably contain NMDA receptors in processes that are
postsynaptic to glutamatergic photoreceptor and bipolar
cells, respectively. These are also sites of high cytochrome
oxidase activity (see above). Presumed amacrine cells
along the vitreal border of INL are immunoreactive for
NMDAR1. A subset of these neurons also exhibits
immunoreactivity for nNOS, suggesting that nNOS in
these cells can indeed be triggered by the activation of
their NMDA receptors. The relatively large number of
both NMDAR1-immunoreactive and nNOS-immunore-
active cells (see below) in the ganglion cell layer indicates
that this relationship is more prevalent than previously
assumed. Besides the feed-forward relationship between
NMDA receptors and NOS, in that entry of calcium
through NMDA receptors stimulate NOS [20], NMDA
receptors themselves have been shown to receive negative
feedback from NO in cultured striatal neurons [65].
Similar mechanism may operate in the retina.
4.6. Nitric oxide (NO) and nitric oxide synthase (NOS)
Nitric oxide, a gaseous neurotransmitter, has recently
been discovered to be both an intercellular and an
intracellular messenger [66]. Its synthesizing enzyme,
nitric oxide synthase, has three known isoforms [21].
Neuronal NOS (nNOS or type I) is a constitutive form
that requires, among other factors, the activation of its
cofactor, calmodulin, which, in turn, is activated by
calcium. The main source of this calcium is thought to
be mediated through voltage-dependent NMDA recep-
tors when the latter’s inhibition by Mg2 is relieved by
the binding of the ligand, glutamate, or its agonist,
NMDA [67–69]. Once synthesized, NO can activate
guanylyl cyclase (GC) to form cGMP, which has wide-
spread cellular functions [70,20,21].
Relatively little is known about the distribution of
nNOS protein in the retina, because of the reported
difficulty in demonstrating its presence by immunocyto-
chemistry. The histochemical marker of NOS, NADPH-
diaphorase, was found only in amacrine cells and
presumed displaced amacrine cells [71–74]. Less is
known about the expression of nNOS gene in the retina
and as yet there has been no report on the distribution
of nNOS mRNA in the retina by in situ hybridization.
The human brain NOS has been cloned [75], but it is
reported to be expressed at low levels in the human retina
[22].
The association of NO with cGMP bears obvious
significance in the retina. cGMP has been known to
mediate the opening of cGMP-gated, non-selective
cation channels found in both the inner and outer
segments of photoreceptors [76,77]. Light triggers a
cascade of events which leads to the hydrolysis of cGMP,
the closing of the channels and hyperpolarization of
photoreceptors (reviewed in [78]). NO is thought to have
two possible functions in photoreceptors: modification of
light response and modulation of synaptic transmission
to horizontal and bipolar cells [79].
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Our anti-neuronal NOS antibodies cross-react with
proteins whose molecular weight corresponds to that of
known nNOS [21]. The consistent labeling of specific
cells, cellular compartments and plexiform layers with
our anti-nNOS antibodies may be attributable to the
presumed accessibility of antigenic site at the amino
terminus of the enzyme. This is a site that is reportedly
unique to neuronal NOS [21]. Thus, our antibodies are
likely to recognize primarily, if not exclusively, neu-
ronal NOS.
Our finding of nNOS in photoreceptor inner seg-
ments confirms previous reports [80–82,34] and is con-
sistent with the notion that NO can facilitate
cGMP-gated conductances in photoreceptor outer seg-
ments and modulate visual transduction [83,79]. In
addition, we found relatively intense labeling in the
outer plexiform layer not previously described (except
for [34] in the rat retina), indicating that NO may play
a significant role in neural transmission within this
synaptic layer. The source of this nNOS is unknown at
present, since the cell bodies of three possible candi-
dates, photoreceptors, bipolars and horizontal cells are
all relatively light in immunoreactivity. However, it is
likely that, as in the case of the inner segments, NOS is
localized to specific neuronal compartments where its
short-lived product, NO, can most effectively exert its
influence. Whether nNOS exists in presynaptic photore-
ceptor terminals and:or in postsynaptic horizontal and
bipolar processes awaits further ultrastructural determi-
nation. NO in the OPL may be involved in a number of
functions: (a) the modification of visual responses in
ON-bipolar cells, which have been reported to have
NO-sensitive soluble guanylate cyclase [84]; (b) modula-
tion of synaptic transmission to OFF-bipolar cells via
its inhibitory action on dopamine release [85] and (c)
affect electrical coupling between horizontal cells re-
ported in lower vertebrates [86]. However, these possi-
ble actions need to be confirmed in the macaque retina.
In addition to the known presence of nNOS-im-
munoreactive amacrine cells [81,34], we have also local-
ized nNOS to punctate distribution along two distinct
bands in the IPL and the ganglion cell layer. These
punctate processes are likely to be synaptic endings of
amacrine cells (some of which can be traced back to the
cell bodies) and:or dendritic processes of NOS-im-
munoreactive ganglion cells. The prevalence of nNOS
in ganglion cells indicates that NO is synthesized there
(see also [34]). Nitric oxide, in turn, may trigger guany-
lyl cyclase, whose message is found in rat ganglion cells
[84]. Guanylyl cyclase then catalyzes the production of
cGMP and cGMP-gated non-selective cation channels
have been reported in retinal ganglion cells [87]. Thus,
NO is likely to significantly influence visual processing
not only in the outer retina, but also at the level of
bipolar-amacrine-ganglion cell synapse.
The presence of nNOS in the retina is further sub-
stantiated by the localization of nNOS gene expression
in retinal ganglion cells and amacrine cells. As in the
case of nNOS proteins, the mRNA levels are moderate
in only a subset of amacrine cells, but they tend to be
quite high in most ganglion cells. Thus, these cells are
fully capable of transcribing and translating nNOS,
whose gene product presumably plays a significant role
in neural transmission through the inner half of the
retina (in addition to the outer half of the retina
discussed above). Our fragment of nNOS cDNA clone
has virtually complete homology with corresponding
sites in the human retinal nNOS cDNA [22]. The
human gene for neuronal NOS has been assigned to
chromosome 12, specifically 12q24.2-\24.31 [88].
4.7. Effect of intra6itreal injections of tetrodotoxin
The voltage-dependent sodium channel blocker, TTX
[25], effectively eliminates all retinal impulses and
blocks both visually guided behavior and post-retinal
light-evoked potentials [8]. Levels of CO appear normal
in photoreceptor inner segments, ONL, OPL and INL
of TTX-treated retinae. This is consistent with the fact
that TTX blocks only the generation of action poten-
tials [25], leaving the slow potentials of the outer retina
intact. The inner plexiform layer and especially the
ganglion cell layer showed a significant reduction in CO
activity (PB0.01). However, there was still a tendency
for the larger cells to be more darkly reactive than the
smaller ones, especially in the central retina. The in-
traretinal axons of ganglion cells also showed a marked
decrease in CO staining as compared to the untreated
eye (PB0.01). Previously, we have found that saline-in-
jected controls contained enzyme levels non-distinguish-
able from normal controls [8] and TTX has no direct
effect on the activity of cytochrome oxidase in an in
vitro, cell-free system (our unpublished observations).
Moreover, the effect of intravitreal TTX is entirely
reversible [2]. Thus, this approach does not result in
any permanent alterations of the metabolic integrity of
the affected retinae. Rather, it demonstrates the dy-
namic ability of mature neurons to respond to changing
functional demands by regulating the level of its en-
ergy-generating enzymes.
Concurrent with changes in CO, the levels of Na
KATPase, NMDAR1 and nNOS proteins, as well as
the expressions of CO subunit genes (CO III and IV)
and nNOS genes are down-regulated in ganglion cells
and the nerve fiber layer, suggesting a global effect on
neurochemical metabolism of spiking neurons. It also
indicates that the regulation of these neurochemicals in
mature retinal neurons is strictly under the control of
neuronal activity.
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